InsiderTrades

Form 4 for STRO SUTRO BIOPHARMA, INC.

Accepted 2021-09-28 00:00:00 ET · period of report 2021-09-24 · accession 0001209191-21-057980 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-09-28 2021-09-24 STRO MOLINA ARTURO MD Chief Medical Off M - OptEx $0.00 +8,609 29.5K +41% $0
D 2021-09-28 2021-09-24 STRO MOLINA ARTURO MD Chief Medical Off F - Tax $19.23 -2,976 26.5K -10% -$57.2K
D 2021-09-28 2021-09-24 STRO MOLINA ARTURO MD Chief Medical Off M - OptEx $0.00 -8,609 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-09-24 M A 8,609 $0.00 29,468 D — —
2 Common Common Stock 2021-09-24 F D 2,976 $19.23 26,492 D — — (F1) Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
3 Derivative Restricted Stock Unit (RSU) 2021-09-24 M D 8,609 $0.00 0 D — · — to 2021-09-26 8,609 Common Stock (F2) Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. (F3) The RSUs vest as to 1/3rd of the total shares annually beginning on September 26, 2019, subject to continued service through each vesting date.